Monashee Investment Management »

Ambrx Biopharma shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Ambrx Biopharma shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Ambrx Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ambrx Biopharma held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ambrx Biopharma by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 208k 14.24

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Structure Therapeutics Sponsored Ads (GPCR)
Aercap Holdings Nv SHS (AER)
PG&E Corporation (PCG)
Korro Bio (KRRO)
Eyepoint Pharmaceuticals Com New (EYPT)
Celldex Therapeutics Com New (CLDX)
Roivant Sciences SHS (ROIV)

View all positions for Monashee Investment Management

Top funds holding Ambrx Biopharma

Darwin Global Management
Cormorant Asset Management
Paradigm Biocapital Advisors
D. E. Shaw & Co
Nextech Invest
Balyasny Asset Management
Citadel Advisors
Logos Global Management
VR Adviser
Vanguard Group
T. Rowe Price Associates
WuXi AppTec
Millennium Management
Goldman Sachs Group
Federated Investors

View all funds holding Ambrx Biopharma